Tempest Therapeutics to present at H.C. Wainwright 28th conference
Tempest Therapeutics, Inc. (TPST) announced it will present at the H.C. Wainwright 28th Annual Global Investment Conference. The company said Matt Angel, Ph.D., is scheduled to present.